Inbeeo has always been extremely proud of our heritage in delivering both excellence and innovation for our clients. Founded in 2018 by Hervé Lilliu, Inbeeo quickly distinguished itself through its unique expertise in delivering tailor-made solutions to address the toughest market access challenges faced by pharmaceutical companies and medical technology suppliers in European, American, and Asian markets. With this commitment still core to everything the Inbeeo team undertakes, we are extremely proud to announce today our joining of Enosium Life Science, an integrated life sciences services group founded by Dr. Antoine Amer.
A New Synergy within the Enosium Life Science Group
This integration into a multi-specialist group offers Inbeeo’s clients a unique opportunity to benefit from data driven, high-value strategic support services across the entire healthcare product value chain. Enosium Life Science, through its three strategic acquisitions—Inbeeo (Strategic Pricing and Market Access), Vyoo Agency (Strategic Health Economics and Market Access), and Epione (Scientific Communication)—is now positioning itself as a key player in Europe, offering a comprehensive and integrated range of services from clinical research to the commercialization of healthcare products.
Using our contact form please do get in touch with the Inbeeo team to find out more about our enhanced offering across Market Access value strategy, HEOR and Medical Affairs as well as what is not too far in the future by way of Regulatory and Marketing expertise support!
Press contact : Florence Portejoie, FP2COM, t. 00 33 6 07 76 82 83, fportejoie@fp2com.fr